Chu Dupuytren

Limoges 87042

3 studies enrolling now · 18 studies all time

What they study most

Acute Lymphoblastic Leukemia, Amyotrophic Lateral Sclerosis, Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s), B-Cell Chronic Lymphocytic Leukemia, Breast Cancer, Carcinoma, Hepatocellular, Chemotherapy-induced Peripheral Neuropathy, Community-acquired Pneumonia, Community-acquired Pneumonia, Influenza, COVID-19, Cytomegalovirus (CMV), Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis, Hormone Refractory Prostate Cancer

Studies at this site

• Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis — Recruiting now
• International CIPN Assessment and Validation Study — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. — Completed
• Observational Study on Inappropriate Therapies — Status unconfirmed
• Early Identification of SEPsis SIGNs in Emergency Department — Completed
• Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest — Completed
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir — Completed
• Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma — Stopped early
• Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence — Completed
• Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
• The eMESH 1 Feasibility Study — Status unconfirmed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed